CD4 and AIDS: Remarkably, the CART approach also showed that the CCL3L1-CCR5 GRGs assist in AIDS prognosis mainly during early-stage disease, such as when baseline CD4 cell counts are greater than 453 cells/mm3, a CD4 cell count threshold that is well above the point at which ART is currently recommended.